Nitric oxide signalling in cardiovascular health and disease

C Farah, LYM Michel, JL Balligand - Nature Reviews Cardiology, 2018 - nature.com
Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in
cardiovascular homeostasis. Tremendous knowledge has been accumulated on the …

New insights in cardiac β-adrenergic signaling during heart failure and aging

C Lucia, A Eguchi, WJ Koch - Frontiers in pharmacology, 2018 - frontiersin.org
Heart failure (HF) has become increasingly common within the elderly population,
decreasing their survival and overall quality of life. In fact, despite the improvements in …

Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy

P Morfino, A Aimo, V Castiglione, C Gálvez-Montón… - Heart failure …, 2023 - Springer
Cardiac fibrosis is characterized by the deposition of extracellular matrix proteins in the
spaces between cardiomyocytes following both acute and chronic tissue damage events …

The beta3 adrenergic receptor in healthy and pathological cardiovascular tissues

LYM Michel, C Farah, JL Balligand - Cells, 2020 - mdpi.com
The third isotype of beta-adrenoreceptors (β3-AR) has recently come (back) into focus after
the observation of its expression in white and beige human adipocytes and its implication in …

Adrenoceptor Desensitization: Current understanding of mechanisms

D Maaliki, AA Jaffa, S Nasser, A Sahebkar… - Pharmacological …, 2024 - Elsevier
G-protein coupled receptors (GPCRs) transduce a wide range of extracellular signals. They
are key players in the majority of biologic functions including vision, olfaction, chemotaxis …

[HTML][HTML] Regulation of β-adrenergic receptors in the heart: a review on emerging therapeutic strategies for heart failure

W Parichatikanond, R Duangrat, H Kurose… - Cells, 2024 - pmc.ncbi.nlm.nih.gov
The prolonged overstimulation of β-adrenergic receptors (β-ARs), a member of the G protein-
coupled receptor (GPCR) family, causes abnormalities in the density and functionality of the …

[Retracted] Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment

B Luo, Y Li, M Zhu, J Cui, Y Liu… - Oxidative medicine and …, 2022 - Wiley Online Library
Intermittent hypoxia (IH) has a dual nature. On the one hand, chronic IH (CIH) is an important
pathologic feature of obstructive sleep apnea (OSA) syndrome (OSAS), and many studies …

Repurposing the β3-adrenergic receptor agonist mirabegron in patients with structural cardiac disease: the beta3-LVH Phase 2b randomized clinical trial

JL Balligand, D Brito, O Brosteanu, B Casadei… - JAMA …, 2023 - jamanetwork.com
Importance Left ventricular (LV) hypertrophy contributes to the onset and progression of
heart failure (HF), particularly for patients with pre-HF (stage B) for whom no treatment has …

[HTML][HTML] Modulation of the nitric oxide/cGMP pathway in cardiac contraction and relaxation: Potential role in heart failure treatment

R Mollace, F Scarano, I Bava, C Carresi… - Pharmacological …, 2023 - Elsevier
Evidence exists that heart failure (HF) has an overall impact of 1-2% in the global population
being often associated with comorbidities that contribute to increased disease prevalence …

Hemodynamic effects of cyclic guanosine monophosphate-dependent signaling through β3 adrenoceptor stimulation in patients with advanced heart failure: A …

H Bundgaard, A Axelsson Raja, K Iversen… - Circulation: Heart …, 2022 - Am Heart Assoc
Background: β3-AR (β3-adrenergic receptor) stimulation improved systolic function in a
sheep model of systolic heart failure (heart failure with reduced ejection fraction [HFrEF]) …